Page last updated: 2024-09-04

myricanol and Leukemia

myricanol has been researched along with Leukemia in 1 studies

*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chai, KQ; Chen, X; Dai, GH; Fan, CJ; Li, ZH; Nie, XJ; Ren, ZM; Tong, YL1

Other Studies

1 other study(ies) available for myricanol and Leukemia

ArticleYear
The mechanistic antitumor study of myricanol 5-fluorobenzyloxy ether in human leukemic cell HL-60.
    Future medicinal chemistry, 2017, Volume: 9, Issue:18

    Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 9; Cyclin-Dependent Kinase Inhibitor p21; Diarylheptanoids; Down-Regulation; Ether; Fas Ligand Protein; fas Receptor; G2 Phase Cell Cycle Checkpoints; HL-60 Cells; Humans; Leukemia; M Phase Cell Cycle Checkpoints; Proto-Oncogene Proteins c-bcl-2; Up-Regulation

2017